Clinical trial Recruiting at 2 sites Interventional Ages 18 to 80

Pulsed vs Conventional Radiofrequency for Tailbone Pain

Official title: Pulsed vs Conventional Radiofrequency of the Ganglion Impar for Coccydynia: A Prospective Randomized Trial

Run by Adana City Training and Research Hospital · NCT07497269 · Data updated 2026-11-12

This study tests whether pulsed or conventional radiofrequency ablation of the ganglion impar better relieves tailbone (coccydynia) pain and improves sleep and quality of life in adults who have not responded to other treatments.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment90 (estimated)
SponsorAdana City Training and Research Hospital
Academic / other
Drugs / interventionsradiation
Locations2 sites (Adana, Adana and 1 other locations)
StatusRecruiting
StartedApril 1, 2026
Main results expectedApril 1, 2027
Study endsApril 1, 2028
Registry record updatedOctober 28, 2026
Trial IDNCT07497269 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–80 with chronic coccygeal pain for more than 3 months, who are scheduled for ganglion impar treatment with either pulsed or conventional radiofrequency ablation and have not responded to conservative therapies.

Probably not a fit

Patients with contraindications to ablation, significant comorbidities, or those unlikely to complete follow-up may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study prospectively compares two radiofrequency ablation approaches targeting the ganglion impar in adults with chronic coccydynia. Participants will undergo either pulsed or conventional radiofrequency ablation and will be followed to assess changes in pain, quality of life, and sleep quality. The trial aims to determine if one technique provides superior pain relief or functional benefits. Eligibility includes adults aged 18 to 80 with at least 3 months of refractory coccygeal pain and planned ganglion impar treatment. Exclusion criteria include incomplete records, procedural failures, infection, bleeding disorders, malignancy, cognitive or language barriers, and other standard safety considerations.

Why it matters

Potential benefit: If successful, this approach could identify a more effective radiofrequency technique for reducing tailbone pain and improving daily functioning.

How similar studies have gone: Similar approaches in nerve-targeted radiofrequency methods have shown variable success, with limited direct comparisons between pulsed and conventional techniques in coccydynia, making this study relatively novel in this indication.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 18 and 80 years.
* Chronic pain in the coccygeal region lasting longer than 3 months, unresponsive to analgesics, anti-inflammatory drugs, and other conservative treatment methods.
* Patients scheduled to undergo ganglion impar treatment with either conventional or pulsed radiofrequency ablation (RFA).

Exclusion Criteria:

* Incomplete medical records.
* Loss to follow-up.
* Technical failure during the block procedure.
* Local infection, bleeding disorders, allergy to contrast agents, or history of spinal surgery.
* History of malignancy.
* Refusal to participate in the study.
* Diagnosed psychological disorders.
* Individuals unable to communicate effectively or understand instructions.
* Age under 18 or over 80 years.

Where it's running

  • Adana City Training and Research Hospital
    Adana, Adana, Turkey (Türkiye)
    Recruiting
  • Tobb Etü Hospital
    Ankara, Ankara, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.